1921
Volume s1-26, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
USD

Abstract

Summary

Studies on the efficacy of atabrine suppression of malaria in American and Australian troops in New Guinea and Australia from June 1943 to January 1945 are presented. The concentration of atabrine present in the plasma of those developing malaria despite supposed suppression is compared with data from adequately suppressed troops. This comparison shows that clinical malaria develops in the presence of inadequate amounts of atabrine. The concentration of atabrine present in “break-throughs” is the same in chronic relapses and “primary” attacks of malaria. It is possible that requires in the field a slightly greater amount of atabrine to be completely suppressed. Our data would support but not establish such a contention. The difference is not great enough to be of practical importance.

The difficulty of obtaining any large number of cases of malaria who consistently claim to have regularly taken 0.1 gram or more of atabrine every day and who have nevertheless developed clear-cut malaria emphasizes the fact that atabrine suppression is mainly a problem of drug administration. However, the development of malaria in an individual can not be taken as definite proof that that individual has failed to take atabrine regularly even if his drug level is low. Variation of drug level obtained with a standard dose is so great that, granting concentration is related to protection, a small percentage would be unprotected by the standard dosage of 0.7 grm of atabrine per week.

The evaluation of several different dosages of atabrine by studies of the concentration of atabrine in the plasma under different conditions and at different times fails to indicate any need for a dosage greater than 0.1 gram per day. Atabrine levels are adequate between doses when 0.4 gram or 0.5 gram is given twice a week. This dosage scheme must be judged on the realtive value of giving the drug fewer times during the week, the increased nausea produced by larger doses, and the greater hazard of more serious reactions when such amounts of atabrine are ingested over a long period.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.1946.s1-26.649
1946-09-01
2017-11-18
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.1946.s1-26.649
Loading

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error